返回
Drug repurposing for stroke intervention
DOI:10.1016/j.drudis.2022.03.003.png)
摘要
En 中文
Despite the availability of advanced interventions, stroke remains one of the most significant causes of mortality and morbidity worldwide. US Food and Drug Administration (FDA)-approved treatment options for stroke include tissue plasminogen activators (tPAs) and mechanical thrombectomy (MT). However, these are limited by a narrow therapeutic time window. Additionally, poststroke rehabilitation therapies can provide functional recovery but take a long time to show benefits. Drug repurposing could be a novel approach to broaden treatment options in this scenario. In this review, we summarize marketed drugs that could be repurposed based on their safety and efficacy data. We also briefly discuss their mechanisms of action and provide a list of repurposed drugs under trials for ischemic stroke therapy.
Keyword:
Ischemic stroke
Drug repurposing
Conventional therapy
Recombinant-tissue plasminogen activator
Mechanical thrombectomy
Drug development
期刊
IF:
7.5
论文数:
6.4K
被引数:
2.3W
机构
引用论文
Studies on the structure-activity relationship and interaction mechanism of flavonoids and xanthine oxidase through enzyme kinetics, spectroscopy methods and molecular simulations
FOOD CHEMISTRY
IF9.8
The potential of drug repurposing combined with reperfusion therapy in cerebral ischemic stroke: A supplementary strategy to endovascular thrombectomy药物再利用联合再灌注治疗缺血性卒中的潜力: 血管内血栓切除术的补充策略
LIFE SCIENCES
IF5.1

